|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2007-12-6
|
|
pubmed:abstractText |
Tamoxifen (TAM) is a selective estrogen receptor modulator (SERM) that is widely used as adjuvant therapy in breast cancer patients; however, it is also associated with undesirable side effects. The goal of this study was to investigate TAM-related side effects, and determine profiles of side effects by race and by smoking status.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1525-1500
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
31
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
384-90
|
|
pubmed:meshHeading |
pubmed-meshheading:18023540-Adult,
pubmed-meshheading:18023540-African Americans,
pubmed-meshheading:18023540-Aged,
pubmed-meshheading:18023540-Aged, 80 and over,
pubmed-meshheading:18023540-Breast Neoplasms,
pubmed-meshheading:18023540-Cross-Sectional Studies,
pubmed-meshheading:18023540-Depression,
pubmed-meshheading:18023540-European Continental Ancestry Group,
pubmed-meshheading:18023540-Female,
pubmed-meshheading:18023540-Humans,
pubmed-meshheading:18023540-Middle Aged,
pubmed-meshheading:18023540-Migraine Disorders,
pubmed-meshheading:18023540-Nausea,
pubmed-meshheading:18023540-Selective Estrogen Receptor Modulators,
pubmed-meshheading:18023540-Smoking,
pubmed-meshheading:18023540-Tamoxifen
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Profiles of tamoxifen-related side effects by race and smoking status in women with breast cancer.
|
|
pubmed:affiliation |
Department of Epidemiology and Preventive Medicine, University of Maryland School of Medicine, Baltimore, MD 21201, USA. mzhan@epi.umaryland.edu
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, Non-P.H.S.
|
